Search Within

William D Travis

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (52)
  2. Journal Article (40)
  3. Book Section (8)
  4. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (101)
  2. GSK Faculty (101)
  3. Human Oncology and Pathogenesis Program (101)
  4. Tow Center for Developmental Oncology (TCDO) (92)
  5. Department of Medicine (70)
  6. Solid Tumor Oncology Division (70)

More Groups

People
  1. Marc Ladanyi (92)
  2. Natasha Rekhtman (69)
  3. Jason Chang (38)
  4. Jennifer Sauter (29)
  5. Charles Rudin (28)
  6. Maria Arcila (22)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (9)
  5. 2021 (12)
  6. 2020 (10)

More Years

Publications
  1. Modern Pathology (30)
  2. Laboratory Investigation (24)
  3. Journal of Thoracic Oncology (11)
  4. Clinical Cancer Research (8)
  5. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (8)
  6. Nature (4)

More Publications

Publishers
  1. Nature Research (30)
  2. Nature Publishing Group (29)
  3. Elsevier Inc. (13)
  4. American Association for Cancer Research (10)
  5. International Agency for Research on Cancer (8)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (101)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic and molecular features to distinguish metastatic urothelial carcinoma in lung from primary lung squamous cell carcinoma
    Meeting Abstract

    Rammal, R.; Darmofal, M.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Fine, S.; Tickoo, S.; Reuter, V.; Travis, W.; Berger, M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Correlation of histologic features with gene alterations in pleural mesothelioma
    Journal Article

    Fanaroff, R. E.; Yang, S. R.; Tan, K. S.; Adusumilli, P. S.; Bodd, F.; Bowman, A.; Chang, J.; Offin, M. D.; Reiner, A.; Rekhtman, N.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Chromothripsis-mediated small cell lung carcinoma
    Journal Article

    Rekhtman, N.; Tischfield, S. E.; Febres-Aldana, C. A.; Lee, J. J. K.; Chang, J. C.; Herzberg, B. O.; Selenica, P.; Woo, H. J.; Vanderbilt, C. M.; Yang, S. R.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma
    Journal Article

    Febres-Aldana, C. A.; Chang, J. C.; Jungbluth, A. A.; Adusumilli, P. S.; Bodd, F. M.; Frosina, D.; Geronimo, J. A.; Hernandez, E.; Irawan, H.; Offin, M. D.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • "Hepatoid" Lung carcinoma demystified: HepPar1/CPS1 expression in carcinomas with solid and granular morphology reflects high mitochondrial content and metabolic reprogramming accompanying STK11/KEAP1/SMARCA4 alterations and is unrelated to hepatocellular differentiation
    Meeting Abstract

    Febres-Aldana, C.; Vanderbilt, C.; Seshan, S.; Richards, A.; Frosina, D.; Jungbluth, A.; Kezlarian, B.; Bodd, F.; Quintanal-Villalonga, A.; Ladanyi, M.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Pathological, clinical and molecular characterization of large cell neuroendocrine carcinoma (LCNEC) of the urinary tract
    Meeting Abstract

    Gandhi, J.; Guercio, B.; Mirsadraei, L.; Zhou, Q.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; Fine, S.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Neurofibromatosis type 2-yes-associated protein and transcriptional coactivator with PDZ-binding motif dual immunohistochemistry is a reliable marker for the detection of neurofibromatosis type 2 alterations in diffuse pleural mesothelioma
    Journal Article

    Li, Y.; Yang, S. R.; Chen, Y. B.; Adusumilli, P. S.; Bialik, A.; Bodd, F. M.; Ladanyi, M.; Lopardo, J.; Offin, M. D.; Rusch, V. W.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library
    Journal Article

    Offin, M.; Sauter, J. L.; Tischfield, S. E.; Egger, J. V.; Chavan, S.; Shah, N. S.; Manoj, P.; Ventura, K.; Allaj, V.; de Stanchina, E.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save